According to Wu Shuo, PR Newswire reports that the American biopharmaceutical company Hoth Therapeutics, Inc. has announced that its board of directors has approved the purchase of up to 1 million USD worth of Bitcoin. Hoth's CEO Robb Knie stated, "We believe that Bitcoin will become a powerful financial reserve asset. The anti-inflation characteristics of Bitcoin may make it a reliable asset with value storage capabilities."